G Protein News and Research

RSS

Caltech-led trial demonstrates feasibility of nanoparticles and RNAi-based therapeutics for treating cancer

A California Institute of Technology -led team of researchers and clinicians has published the first proof that a targeted nanoparticle-used as an experimental therapeutic and injected directly into a patient's bloodstream-can traffic into tumors, deliver double-stranded small interfering RNAs (siRNAs), and turn off an important cancer gene using a mechanism known as RNA interference (RNAi).

22 Mar 2010

Inexpensive lab tests can help protect people from chronic kidney disease

No matter what Washington does on health reform, there's a lot you can do to reform your own health -- and two of the best places to start are your kidneys.

20 Mar 2010

Tips on healthy eating post-surgery

Good nutrition, with adequate calories and protein, is important to healing and recovery after major surgery. But the stress of surgery and follow-up care can depress the appetite, alter the taste of food and make it difficult to eat and digest food, sometimes for weeks or months.

20 Mar 2010

Genetic study may help develop potential treatment strategies for stiff skin syndrome

By studying the genetics of a rare inherited disorder called stiff skin syndrome, researchers at the Johns Hopkins University School of Medicine have learned more about scleroderma, a condition affecting about one in 5,000 people that leads to hardening of the skin as well as other debilitating and often life-threatening problems.

20 Mar 2010

EUREKA project develops unique range of antibodies

EUREKA project E! 3424 RECAN has developed a range of unique and highly specific monoclonal and polyclonal antibodies - the proteins produced in the blood which counteract bacteria, viruses or cancerous cells.

20 Mar 2010

Turning microRNAs into novel drugs

Researchers around the globe are working on turning microRNAs, over 5,000 of which already have been identified, into novel drugs for a wide range of applications, reports Genetic Engineering & Biotechnology News (GEN). These noncoding single-stranded RNAs act through binding to complementary mRNA sequences, thus preventing their translation into protein or accelerating mRNA breakdown, according to the March 15 issue of GEN.

20 Mar 2010

Pressure BioSciences announces presentations on advantages of PCT

Pressure BioSciences, Inc. today announced that five presentations on the advantages of pressure cycling technology (PCT) in the preparation, processing, identification, and quantification of proteins were made at last week's annual meeting of US HUPO (Human Proteomics Organization) in Denver, Colorado.

From Thermo Fisher Scientific Inc. 19 Mar 2010

Genes role in protecting intestinal tract from colitis may lead to potential targets for treatment

Scientists report a protein made by a gene already associated with a handful of human inflammatory immune diseases plays a pivotal role in protecting the intestinal tract from colitis.

19 Mar 2010

Bausch + Lomb ReNu MultiPlus multi-purpose solution named "Best Eye Care Product of the Year - Asia"

Bausch + Lomb ReNu MultiPlus(R) multi-purpose solution has been named "Best Eye Care Product of the Year - Asia" for its revolutionary bottle design at this year's A.S. Watson Global Suppliers Awards. Held in Hong Kong on 4 March 2010, the awards recognize international brands for outstanding performance in bringing innovation, differentiation and excitement to the consumer experience.

19 Mar 2010

Fraunhofer FIT to present IMIKRID and automated protein-level microscope system at HANNOVER MESSE

Proteins, the cellular building blocks, can be visualized and analyzed in great detail today. Here, Fraunhofer FIT presents a fully automated high-performance microscope. One of its diagnostic applications will be to study the complex interactions of proteins between cells. In tumor diagnostics our microscope allows to classify slightly different types of tumors more precisely and to fine-tune therapy accordingly.

19 Mar 2010

FDA categorizes Nanosphere's RVNATSP assay on Verigene SP System as "Moderate Complexity"

Nanosphere, Inc., a leader in the development and commercialization of advanced molecular diagnostics systems, received notification from the U.S. Food and Drug Administration (FDA) that its respiratory virus panel (RVNATSP) performed on the Verigene SP System has been categorized as "Moderate Complexity" under the Clinical Laboratory Improvement Amendments of 1988 (CLIA).

19 Mar 2010

Interfering with dickkopf 1 protein may help in controlling inflammatory bowel diseases

Signals released by immune cells during a bout of inflammatory bowel disease interfere with intestinal cells' ability to regenerate. Yet people with inflammatory bowel diseases have a significantly higher risk of developing colon cancer: a hyper-activation of growth in those same intestinal cells.

19 Mar 2010

Norgen Biotek launches over 30 new kits for NA based diagnostics

Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acids (NA) and protein purification, today announced the launch of over 30 new kits for nucleic-acid based diagnostics. Norgen makes best-in-class kits for nucleic acid and protein sample preparation, and has recognized that high quality sample preparation is the key to high quality diagnostics.

19 Mar 2010

Survey unveils impact of gene regulation on human health

Researchers are only beginning to understand how individual variation in gene regulation can have a lasting impact on one's health and susceptibility to certain diseases. Now, an ambitious survey of the human genome has identified differences in the binding of master regulators called transcription factors to DNA that affect how genes are expressed in different people.

19 Mar 2010

Penn Medicine, AstraZeneca collaborate to generate new AD drug candidates

The University of Pennsylvania and AstraZeneca today announced a new collaborative research agreement to make use of their respective talents and resources in an effort to bridge the transition from drug discovery to development.

19 Mar 2010

Stiff skin syndrome cause found

18 Mar 2010

Malvern image analysis system measures sub-visible particulates in biotherapeutics

Specialists at Malvern Panalytical have demonstrated the application of dynamic particle image analysis to the measurement of sub-visible particulates in biological therapeutics, using the Sysmex FPIA-3000 particle characterization system.

From Malvern Panalytical 18 Mar 2010

Gene regulation rather than genes make us unique

Once the human genome was sequenced in 2001, the hunt was on for the genes that make each of us unique. But scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, and Yale and Stanford Universities in the USA, have found that we differ from each other mainly because of differences not in our genes, but in how they're regulated - turned on or off, for instance.

18 Mar 2010

Genocea Biosciences acquires global license for novel Streptococcus pneumoniae antigens from Children’s Hospital Boston

Genocea Biosciences, a vaccine discovery and development company, today announced an exclusive worldwide license for developed countries to a portfolio of Streptococcus pneumoniae antigens from Children’s Hospital Boston. PATH and Genocea retain certain co-exclusive rights to the antigens for use in developing countries under their collaboration agreements with Children's Hospital Boston.

18 Mar 2010

Modulating body's inflammatory response may help fight serious infection

Treating virulent influenza, sepsis, and other potentially deadly infections long has focused on looking for ways to kill viruses and bacteria. But new research from the University of Utah and Utah State University shows that modulating the body's own overeager inflammatory response to infection may help save more lives.

18 Mar 2010

G Protein News and Research

Caltech-led trial demonstrates feasibility of nanoparticles and RNAi-based therapeutics for treating cancer

Inexpensive lab tests can help protect people from chronic kidney disease

Tips on healthy eating post-surgery

Genetic study may help develop potential treatment strategies for stiff skin syndrome

EUREKA project develops unique range of antibodies

Turning microRNAs into novel drugs

Pressure BioSciences announces presentations on advantages of PCT

Genes role in protecting intestinal tract from colitis may lead to potential targets for treatment

Bausch + Lomb ReNu MultiPlus multi-purpose solution named "Best Eye Care Product of the Year - Asia"

Fraunhofer FIT to present IMIKRID and automated protein-level microscope system at HANNOVER MESSE

FDA categorizes Nanosphere's RVNATSP assay on Verigene SP System as "Moderate Complexity"

Interfering with dickkopf 1 protein may help in controlling inflammatory bowel diseases

Norgen Biotek launches over 30 new kits for NA based diagnostics

Survey unveils impact of gene regulation on human health

Penn Medicine, AstraZeneca collaborate to generate new AD drug candidates

Stiff skin syndrome cause found

Malvern image analysis system measures sub-visible particulates in biotherapeutics

Gene regulation rather than genes make us unique

Genocea Biosciences acquires global license for novel Streptococcus pneumoniae antigens from Children’s Hospital Boston

Modulating body's inflammatory response may help fight serious infection

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News